arrow
J

Jens von der Grün

university hospital zurich and university of zurich
H指数:18
被引数:1,039

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The prospective phase I “Flash-Skin I” trial: ultra-high dose rate radiotherapy implementation and quality assurance at a clinical linear accelerator

前瞻性I期“Flash-Skin I”试验:超高剂量率放射治疗在临床直线加速器上的实施与质量保证

2026-01-090
PRE
Safety in MR-enhanced daily adaptive SBRT Radiotherapy using a conventional C-arm linear accelerator: An FMEA approach

MR增强的每日自适应SBRT放射治疗中使用常规C型臂直线加速器的安全性:FMEA方法

2025-12-010
OAAI
Multicenter analysis of MRI-guided, stereotactic body radiotherapy as ablative treatment for lymph nodal metastases of the abdomen and pelvis

多中心分析MRI引导下立体定向体部放射治疗作为腹盆腔淋巴结转移的消融治疗

2025-10-280
OAAI
Neoadjuvant chemoradiation for patients with resectable locally advanced oral cavity squamous cell carcinoma: Results of the prospective INVERT clinical trial

可切除的局部晚期口腔鳞状细胞癌患者的新辅助放化疗: 前瞻性倒置临床试验的结果

2025-05-010
OA
Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/HPV status

头颈部肿瘤类器官生物样本库,用于根据TP53/HPV状态模拟个体对放射治疗的反应

2025-03-051
OA
Predicting cisplatin tolerability in older adults with head and neck cancer - Insights for improved chemoradiation outcomes
2025-03-011
OAAI
Nivolumab (NIVO) in the first-line (1L) or second-line (2L) and later (2L+) settings in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Updated results from the German non-interventional study (NIS), HANNA

纳武利尤单抗(NIVO)在复发性/或转移性头颈鳞状细胞癌(R/M SCCHN)患者中的一线(1L)或二线(2L)及后续(2L+)治疗中的应用:来自德国非干预性研究(NIS)HANNA的更新结果

2024-09-010
PRE
De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status-results of a prospective multicenter phase II trial (DIREKHT Trial)
2024-08-193
OAAI
A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing De fi nitive Chemoradiation
2024-04-013
OAAI
Potential of ChatGPT in facilitating research in radiation oncology?

ChatGPT在促进放射肿瘤学研究中的潜力?

2023-11-017
OAAI
Patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab (NIVO) in the first-line (1L) or later-line (2L+) settings in Germany: Updated results from the real-world HANNA study
2023-10-010
OAAI
Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer-Results of a large multicenter analysis
2023-04-0113
PRE
Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC
2022-10-068
OAAI